Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for cachexia in incurable upper gastrointestinal adenocarcinomas
2005-000371-18Phase 3Completed
- Sponsor
- Portsmouth Hospitals University NHS Trust
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer anorexia-cachexia syndrome (CACS) and upper gastrointestinal adenocarcinoma comparing Thalidomide with Placebo (2 arms). Primary endpoint: Clinical response rate. Started Aug 2005; status: completed.
02
Drugs
thalidomide
03
Conditions
cancer anorexia-cachexia syndrome (CACS)upper gastrointestinal adenocarcinoma
Beyond the preview
Go deeper on 2005-000371-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000371-18.